Faster insulin aspart (FiASP) vs. apart using an advanced closed-loop system: Extension study evaluating meal-time glucose control
Not Applicable
- Conditions
- type 1 diabetesMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12619001340123
- Lead Sponsor
- Medtronic Diabetes
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Type 1 diabetes of >1 year duration
Stable on insulin pump therapy for >3 months
Proficient in carbohydrate counting
Continuous glucose monitoring (CGM) sensor experience
HbA1c <10.0%
Exclusion Criteria
Pregnancy
eGFR <40ml/min/1.73m2
History of diabetic ketoacidosis or severe hypoglycaemia in the last 3 months
Diabetic gastroparesis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method